You are viewing an incomplete version of our website. Please click to reload the website as full version.

WW Domain Containing Oxidoreductase (WWOX) (N-Term) antibody

Details for Product No. ABIN967262, Supplier: Login to see
Antigen
  • CG7221
  • DmWWOX
  • Dmel\\CG7221
  • anon-EST:Posey177
  • GB11795
  • WWOX
  • D16S432E
  • FOR
  • FRA16D
  • HHCMA56
  • PRO0128
  • SDR41C1
  • WOX1
  • zgc:55975
  • 5330426P09Rik
  • 9030416C10Rik
Epitope
N-Term
24
16
11
9
6
3
3
2
2
2
2
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine)
65
51
12
2
1
1
1
1
1
Host
Rabbit
78
3
3
Clonality
Polyclonal
Conjugate
Un-conjugated
2
2
2
2
2
2
1
Application
Immunohistochemistry (IHC)
73
39
20
10
9
8
6
6
5
2
2
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human WWOX (WW domain-containing oxidoreductase)
Alternative Name WWOX (WWOX Antibody Abstract)
Background WWOX (WW domain-containing oxidoreductase) is a probable oxidoreductase, which acts as a tumor suppressor and plays a role in apoptosis. WWOX may function synergistically with TP53/p53 to control genotoxic stress-induced cell death. WWOX may also play a role in tumor necrosis factor (TNF)-mediated cell death.WWOX interacts with TP53, TP73/p73 and MAPK8. WWOX forms a ternary complex with TP53 and MDM2. WWOX is widely expressed and strongly expressed in testis, prostate, and ovary. Overexpressed in cancer cell lines. Defects in WWOX may be involved in several cancer types. Defects in WWOX may be involved in esophageal squamous cell carcinoma (ESCC)
Synonyms: FOR, WOX1
Research Area Chromatin and Nuclear Signaling, Transcription Factors, Alzheimer's Disease, Apoptosis/Necrosis
Pathways
Restrictions For Research Use only
Product cited in: Park, Ludes-Meyers, Zimonjic et al.: "Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma." in: British journal of cancer, Vol. 91, Issue 4, pp. 753-9, 2004 (PubMed).

Chang, Doherty, Ensign: "JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis." in: The Journal of biological chemistry, Vol. 278, Issue 11, pp. 9195-202, 2003 (PubMed).

Bednarek, Keck-Waggoner, Daniel et al.: "WWOX, the FRA16D gene, behaves as a suppressor of tumor growth." in: Cancer research, Vol. 61, Issue 22, pp. 8068-73, 2001 (PubMed).

Paige, Taylor, Taylor et al.: "WWOX: a candidate tumor suppressor gene involved in multiple tumor types." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 20, pp. 11417-22, 2001 (PubMed).

Ried, Finnis, Hobson et al.: "Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells." in: Human molecular genetics, Vol. 9, Issue 11, pp. 1651-63, 2000 (PubMed).

Bednarek, Laflin, Daniel et al.: "WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer." in: Cancer research, Vol. 60, Issue 8, pp. 2140-5, 2000 (PubMed).

Background publications Aqeilan, Palamarchuk, Weigel et al.: "Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor." in: Cancer research, Vol. 64, Issue 22, pp. 8256-61, 2004 (PubMed).